0001956825-22-000001.txt : 20221205 0001956825-22-000001.hdr.sgml : 20221205 20221205164150 ACCESSION NUMBER: 0001956825-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 EFFECTIVENESS DATE: 20221205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ImmuneSensor Therapeutics, Inc. CENTRAL INDEX KEY: 0001956825 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466598 FILM NUMBER: 221445533 BUSINESS ADDRESS: STREET 1: 2110 RESEARCH ROW STREET 2: SUITE 610 CITY: DALLAS STATE: TX ZIP: 75235 BUSINESS PHONE: 469-387-5398 MAIL ADDRESS: STREET 1: 2110 RESEARCH ROW STREET 2: SUITE 610 CITY: DALLAS STATE: TX ZIP: 75235 D 1 primary_doc.xml X0708 D LIVE 0001956825 ImmuneSensor Therapeutics, Inc. 2110 RESEARCH ROW SUITE 610 DALLAS TX TEXAS 75235 469-387-5398 DELAWARE None None Corporation true 2019 Qingsong Li 2110 Research Row Suite 610 Dallas TX TEXAS 75235 Executive Officer Director Ernest Wong 2110 Research Row Suite 610 Dallas TX TEXAS 75235 Executive Officer Director Ning Zhang 2110 Research Row Suite 610 Dallas TX TEXAS 75235 Director Zhi Hong 2110 Research Row Suite 610 Dallas TX TEXAS 75235 Director Biotechnology Decline to Disclose 06b false 2022-11-18 false true false 0 20000000 10000000 10000000 false 1 0 0 0 false ImmuneSensor Therapeutics, Inc. /s/ Qingsong Li Qingsong Li Chairman 2022-12-05